Disease | retinal disease |
Phenotype | C0242852|proliferative vitreoretinopathy |
Sentences | 2 |
PubMedID- 20463795 | In terms of triamcinolone, tano and machemer originally reported that intravitreal injection of triamcinolone was effective to proliferative vitreoretinal diseases with an experimental proliferative vitreoretinopathy model.47 several reports demonstrated that intravitreal injection of triamcinolone is effective in retinal disease such as retinal leakage48 and subretinal neovasculation49 in animal models. |
PubMedID- 25342193 | Primary surgical failure) except cataract surgery, recurrent retinal detachment, macular hole, epiretinal membrane, proliferative vitreoretinopathy grade c, history of trauma, other retinal diseases, and diabetes mellitus. |
Page: 1